Advancing Value-Based Contracting Partnership Forum


VBC_Image 
 
 

The AMCP Partnership Forum, Advancing Value-Based Contracting, which took place on June 20-21, 2017, resulted in important consensus on addressing the operational, legal and regulatory changes needed to fully leverage this new payment system for health care.

Participants considered topics such as defining value-based contracting; understanding performance metrics and measures for value; developing solutions for patient management-related hurdles; identifying therapeutic areas that represent “early adoption”    opportunities; and addressing legal and regulatory changes that would drive the adoption of these contracts, including those related to anti-kickback laws and Medicaid best price requirements.

The Forum was attended by more than 30 national and regional health care leaders representing health plans, integrated delivery systems, pharmacy benefit managers, data and analytics experts, and biopharmaceutical companies.

The Forum was moderated by Susan Winckler, Chief Risk Management Officer, Leavitt Partners and Former Chief of Staff of the US Food and Drug Administration.

The Forum was held in partnership with Amgen, Bristol-Myers Squibb, Lilly & Co., Merck, the National Pharmaceutical Council, Novartis, Premier, Pharmaceutical Research and Manufacturers of America, RxAnte, Takeda and Xcenda.

Additional Materials: 

▶  Forum Program 

Forum Press Release 

Forum Proceedings 

Forum Webinar scheduled for October 11, 2017  

If you have any questions, please contact Charlie Dragovich, BSPharm, AMCP's Vice President, Strategic Alliances and Corporate Services at cdragovich@amcp.org or 703-684-2610.